34586 - Asthma: Drugs (Answered)

Derek Twigg
To ask the Secretary of State for Health, how much was spent by the NHS on asthma drugs in each year since 2010.

George Freeman

Information on National Health Service expenditure on drugs for the treatment of asthma1 in primary and secondary care is shown in the table.

Since some drugs are prescribed to treat more than one condition and as the condition for which a drug is prescribed is not collected, it is not possible to specify the different conditions for which a drug may have been prescribed. The information provided may therefore include costs from the prescribing of drugs that treated conditions other than asthma.

Cost of drugs for the treatment of asthma, England2

Year

Primary care (£ millions)

Secondary care (£ millions)

Combined total (£ millions)

2010

952.4

43.9

999.3

2011

968.5

45.1

1,013.6

2012

1,007.5

49.0

1,056.5

2013

1,018.3

52.4

1,070.7

2014

1,031.2

56.1

1,087.2

2015 3

1,039.4

-

-

Sources: Prescription Cost Analysis (PCA) system data provided by the Health and Social Care Information Centre (primary care). Hospital Pharmacy Audit Index (HPAI) provided by IMS Health (secondary care).

Notes:

1 Drugs for the treatment of asthma have been defined as those included in the following British National Formulary (BNF) sections, using the classification system prior to edition 70:

3.1.1 Adrenoceptor agonists

3.1.2 Antimuscarinic bronchodilators

3.1.3 Theophylline

3.2 Corticosteroids

3.3.1 Cromoglicate and related therapy

3.3.2 Leukotriene receptor antagonists

3.4.2 Allergen immunotherapy (omalizumab only)

2 Cost of drugs at NHS list price not taking account of discounts, dispensing costs, fees or prescription charges income. Totals may not add up due to rounding.

3 Secondary care data for 2015 is not yet available.